Category: coronavirus

Gauging growth in the most challenging environment in decades

Michael Whitmire, CPA Contributor Michael Whitmire, CPA, is co-founder and chief executive officer at Los Angeles-based FloQast, Inc., a developer of accounting close management software. Traditionally, measuring business success requires a greater understanding of your company’s go-to-market lifecycle, how customers engage with your product and the macro-dynamics of your market.…

Read More

Moderna set to start final-stage trial of its coronavirus vaccine by July

Pharmaceutical company Moderna told Bloomberg on Thursday that it’s on pace to begin the final-stage clinical trial of its vaccine for the novel coronavirus that causes COVID-19 by July. Moderna was the first company to begin human clinical trials of its vaccine candidate in the U.S., and the last stage…

Read More

Airbnb, Lyft and Uber: when to call a it a comeback

As Uber and Lyft reached their public-market nadir in mid-March, you would have been forgiven for thinking they were heading under. If the markets are somewhat efficient, why else would America’s top two ride-hailing companies shed two-thirds and three-quarters of their value, respectively, in just over a month? As we…

Read More

EPA orders Amazon and eBay to remove products posing as coronavirus remedies

The Environmental Protection Agency (EPA) has ordered Amazon and eBay to stop selling products that falsely claim to kill coronavirus. Around 70 products were specified in the EPA’s order, including paint stripper, tablets containing chlorine dioxide… Source

Read More

Theaters are ready to reopen, but is America ready to go back to the movies?

Last week, AMC marked its earnings report with a somber note. The movie theater giant warned of losses reaching up to $2.4 billion, courtesy of COVID-19-related closures, adding that “substantial doubt exists about our ability to continue as a going concern for a reasonable period of time.” AMC isn’t alone.…

Read More

Cue Health raises $100 million to speed development of rapid, portable COVID-19 diagnostics

San Diego-based startup Cue Health has closed a $100 million Series C funding round, including participation from Decheng Capital, Foresite Capital, Madrone Capital Partners, Johnson & Johnson Innovation, ACME Capital and others. The funding will be used to help Cue finish up development, validate and scale production of its Cue…

Read More